位置:成果数据库 > 期刊 > 期刊详情页
体外诱导K562细胞尼洛替尼耐药及其机制的初步探讨
  • ISSN号:0253-2727
  • 期刊名称:中华血液学杂志
  • 时间:2012.11.11
  • 页码:906-910
  • 分类:R733[医药卫生—肿瘤;医药卫生—临床医学]
  • 作者机构:贵州医科大学附属医院血液科/贵州省造血干细胞移植中心/贵州省血液病诊疗质控中心,贵阳550004
  • 相关基金:国家自然科学基金资助项目(81070444,81270636);贵阳市科技局筑科合同[(20141001)47号].
  • 相关项目:逆转录病毒介导HO-1对造血干细胞的保护性效应与减轻GVHD及机理研究
作者: 王季石|
中文摘要:

目的 探讨自体造血干细胞移植(auto-HSCT)治疗淋巴瘤患者移植相关并发症的预防及处理,同时比较不同预处理方案的疗效及不良反应。方法 选择2006年6月至2015年6月于该院血液科行auto-HSCT治疗的87例淋巴瘤患者作为研究对象。按照移植预处理方案不同,将其分为BEAM方案预处理组(41例)和BEAC方案预处理组(46例)。结果 两组患者的性别、年龄、淋巴瘤分期、中位随访时间及病理类型等差异均无统计学意义(P〉0.05)。87例患者均成功获得造血重建,BEAC组与BEAM组比较,中性粒细胞植入时间差异无统计学意义[11(8-15)d vs.12(8-16)d,P=0.589 7],而血小板植入时间BEAC组优于BEAM组[13(10-17)d vs.15(11-19)d,P=0.015 3]。两组患者预处理不良反应相似,无肝静脉闭塞病及移植相关死亡发生。中位随访61(3-120)个月,预期3年生存率分别为83.23%和86.56%(P=0.639 3),5年生存率分别为69.47%和77.60%(P=0.479 9)。结论 BEAM和BEAC预处理方案auto-HSCT都是治疗淋巴瘤安全、有效的方法,其远期疗效尚待长期随访观察。

英文摘要:

Objective To investigate the prevention and treatment of transplant-related complications,and compare the effi- cacy and adverse effects of different conditioning regiment after autologous hematopoietic stem cell transplantation (auto-HSCT) for lymphoma patients. Methods Between June 2006 and June 2015,87 consecutive patients with lymphoma treated with auto- HSCT were received in hematology department of our Hospital. According to conditioning regiment,the patients were divided into BEAM conditioning regiment group (n= 41) and BEAC conditioning regiment group (n= 46). Results Between the two groups, the distribution of gender,age, lymphoma stage, the median follow-up time and the pathological type were not significantly different (P〉0.05). All patients achieved hematopoietic reconstruction successfully. The median time to neutrophil engraftment was 11 days (range 8-15 days) in BEAC group and 12 days (range 8-16 days) in BEAM group (P= 0. 589 7). The median time of platelet engraftment in BEAC group ( 13 days, range 10- 17 days) was superior than that in BEAM group ( 15 days, range 11 - 19 days), with significant difference(P=0. 015 3). The adverse effects of conditioning regiment in both groups were similar, there was no he- patic vein occlusion disease and transplant-related deaths occurred. The 3-year survival rate for the BEAC and BEAM groups was 83.23% and 86. 56% respectively(P= 0. 639 3). The 5-year survival rate for the BEAC and BEAM groups was 69.47% and 77.60% respectively (P= 0. 479 9). Conclusion The results show that BEAM and BEAC conditioning regiment are safe and effec- tive for lymphoma with auto-HSCT,however,the long-term efficacy will wait for the long-term follow-up.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中华血液学杂志》
  • 中国科技核心期刊
  • 主管单位:中国科学技术协会
  • 主办单位:中华医学会
  • 主编:
  • 地址:天津市南京路288号
  • 邮编:300020
  • 邮箱:cnblood82@yahoo.com.cn
  • 电话:022-27304167
  • 国际标准刊号:ISSN:0253-2727
  • 国内统一刊号:ISSN:12-1090/R
  • 邮发代号:6-54
  • 获奖情况:
  • 中国期刊方阵“双效”期刊
  • 国内外数据库收录:
  • 美国化学文摘(网络版),荷兰文摘与引文数据库,美国生物医学检索系统,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:25538